Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Oxycodone Drugs Market Size Shifted, And What Is the Outlook Through 2034?

There has been significant growth in the oxycodone drugs market size in recent years. It is projected to increase from $5.62 billion in 2024 to $6.04 billion in 2025, representing a compound annual growth rate (CAGR) of 7.4%. This spike in the historical period came as a result of robust marketing strategies for oxycontin. The drug was mainly advertised for chronic non-malignant pain and cancer. As more oxycontin prescriptions were issued for non-cancer pain, the need for these drugs escalated. Furthermore, the post-world war II era witnessed a surge in the introduction of synthetic opiates like oxycodone in the market.

How Much Will the Oxycodone Drugs Market Be Worth in 2029?

Predictions suggest a significant expansion in the oxycodone drugs market in coming years, with projected growth rising to $7.92 billion by 2029 at a compound annual growth rate (CAGR) of 7.0%. The upward trend is linked to a number of factors including an upsurge in chronic pain conditions, an increase in surgical procedures, continuous advancement in the product pipeline, improvements in drug delivery methods, and an aging global population experiencing higher rates of chronic discomfort. In addition, the forecast period is expected to see enhanced demand for abuse-deterrent formulations (ADFS), the creation of innovative delivery systems, an increase in the application of combination therapies, and evolution in production technology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp

Which is the Largest Company in the Oxycodone Drugs Market?

Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd., Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences

What Are the Main Market Drivers in the Oxycodone Drugs Industry?

The escalating prevalence of orthopedic ailments is poised to stimulate the expansion of the oxycodone drug market. Orthopedic disorders encompass an array of musculoskeletal issues, involving bones, joints, ligaments, tendons, and muscles, which result in pain, reduced motion, and functional restrictions. Factors contributing to the increased occurrence of orthopedic disorders include aging demographics, inactive lifestyles, obesity, sports-related injuries, and work-related risks. Oxycodone medications are employed in managing orthopedic disorders to relieve severe and chronic pain caused by conditions like fractures, joint damage, or discomfort following surgery, by effectively targeting the pain receptors in the central nervous system. For example, in October 2023, predictions from the Institute for Health Metrics and Evaluation, a US-based research institute, indicate that the projected figure for musculoskeletal disorders (orthopedic disorders) is set to increase by 115% (within a range of 107–124%) from 2020 to 2050, escalating to an estimated total of 1,060 million prevalent cases by 2050. Consequently, the overwhelming prevalence of orthopedic disorders is propelling the growth of the oxycodone drug market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=15886&type=smp

How Is the Oxycodone Drugs Market Segments Structured?

The oxycodone drugs market covered in this report is segmented –

1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone

2) By Dosage Form: Tablets, Capsules, Injections

3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Short Acting Oxycodone: Immediate-Release Oxycodone Tablets, Oxycodone Oral Solution

2) By Long Acting Oxycodone: Extended-Release Oxycodone Tablets, Oxycodone Controlled-Release Formulations

What Strategic Trends Are Transforming the Oxycodone Drugs Market?

Top corporations in the oxycodone drug market are concentrating their resources on creating innovative medications, like oxycodone immediate-release (IR) tablets, in an effort to curb drug misuse through injection and intranasal methods. Oxycodone immediate-release (IR) tablets are a type of oxycodone, a powerful painkiller, structured to give speedy pain alleviation. For instance, Protega Pharmaceuticals LLC, an American pharmaceutical firm, introduced RoxyBond (oxycodone) immediate-release (IR) tablets in the United States in July 2022. The U.S. Food and Drug Administration (FDA) has approved RoxyBond as an opioid agonist for the management of severe pain which requires the use of an opioid analgesic if other treatments are not sufficient. It’s designed with sophisticated technology to discourage misuse and abuse, making it challenging to tamper with in either a physical or chemical way.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report

Which Global Regions Offer the Highest Growth in the Oxycodone Drugs Market?

North America was the largest region in the oxycodone drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oxycodone drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15886

This Report Delivers Insight On:

1. How big is the oxycodone drugs market, and how is it changing globally?

2. Who are the major companies in the oxycodone drugs market, and how are they performing?

3. What are the key opportunities and risks in the oxycodone drugs market right now?

4. Which products or customer segments are growing the most in the oxycodone drugs market?

5. What factors are helping or slowing down the growth of the oxycodone drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model